mannose has been researched along with naphthoquinones in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; He, Z; Huang, Y; Tang, Y; Wang, B; Wang, H; Xu, Q; Zhang, M | 1 |
| Cai, K; Hu, Y; Li, M; Liu, Y; Luo, Z; Wang, X; Xue, C; Zhao, Y | 1 |
2 other study(ies) available for mannose and naphthoquinones
| Article | Year |
|---|---|
Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1.
Topics: Azepines; Biomimetics; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dendritic Cells; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Lactoferrin; Lectins, C-Type; Low Density Lipoprotein Receptor-Related Protein-1; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Nanoparticles; Naphthoquinones; Neoplasms; Receptors, Cell Surface; Triazoles; Tumor Microenvironment | 2019 |
A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses.
Topics: DNA; Ferritins; Humans; Immunity, Innate; Manganese; Mannose; Membrane Proteins; Naphthoquinones; Neoplasms; Nucleotidyltransferases; Serum Albumin, Bovine; Tumor Microenvironment | 2022 |